Anaphylaxis to patent blue dye: a case report

Authors

  • Margarida Marcelino Resident of Anesthesiology Department Instituto Português de Oncologia de Lisboa Francisco Gentil - Lisboa, Portugal
  • Rita Ferreira Anesthesiology Department Instituto Português de Oncologia de Lisboa Francisco Gentil - Lisboa, Portugal
  • Paula Costa Anesthesiology Department Instituto Português de Oncologia de Lisboa Francisco Gentil - Lisboa, Portugal

DOI:

https://doi.org/10.25751/rspa.4077

Keywords:

Anaphylaxis/chemically induced, Breast Neoplasms, Coloring Agents, Rosaniline Dyes/adverse effects

Abstract

Patent blue dye is one of the synthetic dyes used in the identification of sentinel lymph nodes in patients with breast cancer. The administration of dyes is becoming increasingly frequent in surgeries and under general anesthesia the early signs of anaphylaxis may be undetected.

A 56 year-old woman with breast cancer was submitted to mastectomy under general anesthesia. After the anesthetic induction and administration of the dye, the patient exhibited facial and limb rash and hypotension. Anaphylaxis was suspected, so the patient was treated as per protocol, with partial recovery, and the surgery was postponed.

Given the oncological context, surgery took place a few days later; some drugs were altered, patent blue dye was avoided and an allergic reaction prevention protocol was established. The surgery was performed without complications; afterwards allergy to patent blue dye was confirmed through prick tests.

Downloads

Download data is not yet available.

Downloads

Published

2014-04-01

How to Cite

Marcelino, M., Ferreira, R., & Costa, P. (2014). Anaphylaxis to patent blue dye: a case report. Journal of the Portuguese Society of Anesthesiology, 23(2), 49–51. https://doi.org/10.25751/rspa.4077

Issue

Vol. 23 No. 2 (2014)

Section

Case Report

License

Articles are freely available to be read, downloaded and shared from the time of publication.

The RSPA reserves the right to commercialize the article as an integral part of the journal (in the preparation of reprints, for example). The author should accompany the submission letter with a declaration of copyright transfer for commercial purposes.

Articles are published under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC).

After publication in RSPA, authors are allowed to make their articles available in repositories of their home institutions, as long as they always mention where they were published.